Low Toxicity and Favorable Overall Survival in Relapsed/Refractory B-ALL following CAR T cells and CD34-selected T Cell Depleted Allogeneic Hematopoietic Cell Transplant.

To define the tolerability and outcome of allogeneic hematopoietic stem cell transplant (allo-HSCT) following CAR T cell therapy, we retrospectively reviewed pediatric/young adult patients with relapsed/refractory B-ALL who underwent this treatment. Fifteen patients (median age 13 years; range 1–20...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabrizio, Vanessa A., Kernan, Nancy A., Boulad, Farid, Cancio, Maria, Allen, Jennifer, Higman, Meghan, Margossian, Steven P., Mauguen, Audrey, Prockop, Susan, Scaradavou, Andromachi, Shah, Niketa, Spitzer, Barbara, Stieglitz, Elliot, Yeager, Nicholas, O’Reilly, Richard J., Brentjens, Renier J., Boelens, Jaap Jan, Curran, Kevin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606268/
https://www.ncbi.nlm.nih.gov/pubmed/32390002
http://dx.doi.org/10.1038/s41409-020-0926-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606268/
https://www.ncbi.nlm.nih.gov/pubmed/32390002
http://dx.doi.org/10.1038/s41409-020-0926-1

Ejemplares similares